View Cart (0 items)

Pharmaceutical

Pharmaceutical industry in strategic crisis, report says

No Comments
Increasing price and cost pressure, regulatory changes and expiring patents are leading to shrinking margins in the pharmaceutical industry.
Read More

Operations halted at pharmaceutical plant after discovery of potential explosives

No Comments
A pharmaceuticals factory in Wales has been closed following the discovery of potentially explosive chemicals on site.
Read More

Pfizer to acquire NextWave Pharmaceuticals

No Comments
NEW YORK — Pfizer Inc. has agreed to acquire NextWave Pharmaceuticals, a specialty pharmaceutical company that specializes in products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related
Read More

Dow Chemical collaborates with Bend Research to develop drug-solubility solutions

No Comments
MIDLAND, Mich. and BEND, Ore. — Dow Chemical and drug-formulation development and manufacturing company Bend Research Inc. are collaborating to provide science-based spray-dried dispersion (SDD) solutions and select enabling
Read More

Antares Pharma receives development milestone payment

No Comments
EWING, N.J. -- Antares Pharma, Inc. announced that its partner Pfizer Inc. achieved a development milestone related to its undisclosed Consumer Healthcare product. This development milestone in Antares’ collaboration with Pfizer
Read More

Valeant Pharmaceuticals acquires Visudyne From QLT

No Comments
MONTREAL — Valeant Pharmaceuticals International, Inc. says it has acquired Visudyne, used to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration,
Read More

Bayer HealthCare to acquire Teva U.S. animal health business

No Comments
SHAWNEE, Kan. and JERUSALEM — Bayer HealthCare LLC and Teva Pharmaceutical Industries Ltd. say they have signed an agreement in which Bayer will acquire the U.S. based animal health
Read More

Valeant Pharmaceuticals to acquire Medicis Pharmaceutical Corp.

No Comments
MONTREAL and SCOTTSDALE, Ariz. — Valeant Pharmaceuticals International and Medicis Pharmaceutical Corp. have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock
Read More

Pharmaceutical company to create 200 jobs in North Carolina

No Comments
RALEIGH, N.C. — Pharmaceutical company Hospira plans to invest at least $85 million over the next three years to modernize and expand its operations in Nash County, N.C., Gov.
Read More

Pascal Soriot appointed CEO of AstraZeneca

No Comments
LONDON — Pascal Soriot has been appointed as AstraZeneca’s chief executive officer, the company announced. Simon Lowth remains as AstraZeneca’s interim CEO until Pascal Soriot joins. At that point,
Read More